title: Therapeutic options in advanced prostate cancer: present and future.
abstract: Patients with advanced prostate cancer now have many treatment options available including first- and second-line hormonal therapy, radiotherapy, bisphosphonate therapy with zoledronic acid, and taxane-based chemotherapy. These options now give clinicians an opportunity to offer their patients symptomatic relief and most importantly improve overall survival. This article reviews the current treatment options available for men with advanced prostate cancer. In addition, novel treatment options under development, including calcitriol, immunotherapies, small molecule inhibitors, and nucleotide-based targeted therapy, are discussed.
authors.forename: Richard D
authors.initials: RD
authors.lastname: Sowery
authors.forename: Alan I
authors.initials: AI
authors.lastname: So
authors.forename: Martin E
authors.initials: ME
authors.lastname: Gleave
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001918:Brachytherapy / Q000592:standards / Q000639:trends; D002117:Calcitriol / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy / Q000592:standards / Q000639:trends; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D019496:Cancer Vaccines; D002117:Calcitriol